--- title: "​​Senior Director, Regulatory Affairs – Infectious Disease​" company: "Tonix Pharmaceuticals" company_url: "https://www.remjobs.works/companies/tonix-pharmaceuticals" url: "https://www.remjobs.works/job/tonix-pharmaceuticals-senior-director-regulatory-affairs-infectious-disease-e413e8a3-c203-4b7d-855d-821dc0d9d6ab" apply_url: "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4415174009" workplace: onsite location: "Berkeley Heights, NJ or Frederick, MD" employment_type: unspecified seniority: director role: other region: united-states salary: "$200,000–$250,000" date_posted: 2026-09-22T17:41:29.000Z first_seen_by_remjobs: 2026-09-22T17:42:24.205Z --- # ​​Senior Director, Regulatory Affairs – Infectious Disease​ **Tonix Pharmaceuticals** · Berkeley Heights, NJ or Frederick, MD Salary: $200,000–$250,000 Apply: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4415174009 ## About Tonix Pharmaceuticals Tonix is a clinical-stage biopharmaceutical company focused on developing novel therapies and vaccines to prevent and treat central nervous system disorders, immunology conditions, infectious diseases, and rare diseases. ## About the role Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix’s CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti-*Borrelia* OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit [www.tonixpharma.com](https://nam10.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.globenewswire.com%2FTracker%3Fdata%3D9p5FBvlzG2u-9NzVEDdUgRNdl57Mw08p4h9XviYYnbwVJ-X_DNEOeN4RdGA64IhTnk9R4lQWNXhq0g8TrvoRTCZSpqmowBapMZCbqP_sxm0%3D&data=05%7C02%7Cmarsha.ihrig%40tonixpharma.com%7C016ba434378242bb501908dea48d8908%7C9f3c9f8851ca4393815e405a5f206a29%7C0%7C0%7C639129124987080441%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=WrmW8ZuY9XRYJZM0BMPu3thoab5uVHnt9SqBNHIoDuU%3D&reserved=0) and follow the Company on [LinkedIn](https://nam10.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.globenewswire.com%2FTracker%3Fdata%3DbldblPUeLBo2VtrimIDsthVk4RaPH1sCjnDw18J2Q9UGKOYpi7kKsd6NuJ4rb7a1ocGevguAt4l_8t8TE5rfCP1YmSBTJO1HR9Uo9KAv_DEwtbEkJhm1CdLRAEbAUNB-&data=05%7C02%7Cmarsha.ihrig%40tonixpharma.com%7C016ba434378242bb501908dea48d8908%7C9f3c9f8851ca4393815e405a5f206a29%7C0%7C0%7C639129124987109283%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=dHRzyv5dfKFOhCroh809txjNcJOjNrBSQRyfSgHaIu8%3D&reserved=0) and [X](https://nam10.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.globenewswire.com%2FTracker%3Fdata%3D0NgIEJjy96AytWlfgCqgqVv5cOeUVkGOTFS78koSy22XXOczOtXjxSorNUcN-uDTk4CYVQkJndgCk6o2RQBlKQ%3D%3D&data=05%7C02%7Cmarsha.ihrig%40tonixpharma.com%7C016ba434378242bb501908dea48d8908%7C9f3c9f8851ca4393815e405a5f206a29%7C0%7C0%7C639129124987130654%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=frLcoK5ETOWzJq9lmvkirCS8HaHc2WCX%2Fg4ESMSdLgk%3D&reserved=0). **Tonix’s product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication.* Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. **Position Overview** The Senior Director, Regulatory Affairs for Infectious Disease will serve as the senior Regulatory Lead for Tonix’s assigned infectious disease biologics and vaccine programs, providing strategic leadership from early development through initial product registration. The role will shape global development and regulatory plans, lead health authority strategy and interactions, and integrate regulatory input across clinical, nonclinical, and CMC disciplines. The ideal candidate is a strategic, proactive leader who can independently navigate complex regulatory issues, anticipate regulatory and business needs, influence development strategy, and provide clear recommendations to cross-functional teams and senior leadership. **Key Responsibilities** - Serve as the senior Regulatory Lead for biologics, focused on infectious disease programs, providing strategic regulatory leadership across assigned programs. - Develop, lead, and execute global regulatory strategies across nonclinical, CMC, clinical development, registration, commercialization, and lifecycle management. - Lead preparation, authorship, and coordination of regulatory submissions across the product lifecycle, including pre-IND packages, INDs, amendments, briefing documents, marketing applications, supplements, and post-approval submissions. - Serve as a senior regulatory representative in interactions with FDA and other global health authorities; lead regulatory meetings, negotiations, and responses to complex regulatory issues. - Provide regulatory leadership for commercial and post-approval activities, including product labeling, promotional considerations, lifecycle management, and implementation of post-marketing commitments and requirements. - Lead cross-functional regulatory efforts by partnering with nonclinical, CMC, clinical, commercial, medical affairs, project management, and external partners/CROs. - Anticipate and assess regulatory risks, impacts, and mitigation strategies; provide strategic recommendations to cross-functional teams and senior leadership. - Ensure compliance with FDA, ICH, and global regulatory requirements, as well as internal SOPs and GxP standards. - Oversee regulatory documentation quality and timely delivery of program milestones. - Ability to manage multiple responsibilities in a fast‑paced, dynamic environment. - Comfortable operating in a fast-paced biopharmaceutical environment, with the ability to roll up your sleeves, work hands-on, and adapt as priorities evolve. - Ability to travel up to 20%. **Qualifications** - Bachelor’s degree in biological sciences, pharmaceutical sciences, or a related field; an advanced scientific degree is strongly preferred. - Minimum of 12 years of progressively responsible regulatory affairs experience, including substantial experience leading global regulatory strategy for vaccine or infectious disease development programs. - Significant regulatory experience with prophylactic or therapeutic vaccines, infectious disease biologics, or closely related products, supported by a strong scientific foundation in immunology, infectious diseases, or related disciplines. - Experience serving as a Global Regulatory Lead or equivalent accountable regulatory leader for complex development programs. - Proven experience guiding programs from early development through marketing application preparation or submission, including INDs or CTAs, briefing packages, agency responses, and BLAs or MAAs. - Demonstrated experience leading FDA interactions, working with other major global health authorities, and translating agency feedback into actionable development plans. - Experience leading multidisciplinary regulatory teams and influencing cross-functional development and governance decisions. - Strong knowledge of FDA, ICH, EU, and applicable global regulatory requirements and guidelines. - Excellent written, verbal, and executive-level communication skills, including regulatory writing and presentation of complex regulatory recommendations. - Experience mentoring and developing regulatory professionals, with or without direct reporting relationships. - Strong organizational, planning, and prioritization skills with high attention to detail. Salary Range$200,000—$275,000 USD***Please note that Tonix does not offer sponsorship for this role.** **Recruitment & Staffing Agencies** Tonix does not accept agency resumes unless contacted directly by internal Tonix Talent Acquisition. Please do not forward resumes to Tonix employees or any other company location; Tonix is not responsible for any fees related to unsolicited resumes. **Compensation & Benefits** Tonix provides a comprehensive compensation and benefits package which includes: - Medical, Dental & Vision Insurance, Basic and Voluntary Life and AD&D Insurance, Short- and Long-Term Disability Insurance, Flexible Spending Accounts, Health Savings Account, and Employee Assistance Programs - Pet Insurance - Retirement Savings 401k with company match and annual discretionary stock options - Generous Paid Time Off, Sick Time, & Paid Holidays - Career Development and Training Tonix provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, sex, national origin, age, genetics, or any other characteristic protected by law. In addition to federal law requirements, Tonix complies with applicable state and local laws governing nondiscrimination in employment. This policy applies to all terms and conditions of employment, including recruiting, hiring, placement, promotion, termination, layoff, recall, transfers, leaves of absence, compensation, and training. Tonix expressly prohibits any form of workplace harassment based on race, color, religion, gender, sexual orientation, gender identity or expression, national origin, age, genetic, information, disability, veteran status, or any other characteristic protected by law. --- Source: Tonix Pharmaceuticals's own career page, read by RemJobs. Canonical HTML version: https://www.remjobs.works/job/tonix-pharmaceuticals-senior-director-regulatory-affairs-infectious-disease-e413e8a3-c203-4b7d-855d-821dc0d9d6ab